PF-04634817
目录号: A18659
CCR2 /CCR5 dual 拮抗剂
PF-04634817 是一种口服 CCR2 和 CCR5 趋化因子受体拮抗剂,用于治疗糖尿病肾病和糖尿病性黄斑水肿。
Discription | PF-04634817 is an orally administered CCR2 and CCR5 chemokine receptor antagonist, for the treatment of diabetic nephropathies and diabetic macular oedema. | ||
---|---|---|---|
Targets |
|
目录号 | A18659 |
---|---|
分子式 | C25H36F3N5O3 |
分子量 | 511.59 |
CAS号 | 1228111-63-4 |
SMILES | O=C([C@]1(C(C)C)C[C@H](N[C@@H]2[C@H](OC)COCC2)CC1)N3[C@](C4)([H])CN(C5=NC=NC(C(F)(F)F)=C5)[C@]4([H])C3 |
其他名称 | PF-04634817; PF 04634817; PF04634817; PF-4634817; PF 4634817; PF4634817. |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2